144 related articles for article (PubMed ID: 3654999)
1. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
[TBL] [Abstract][Full Text] [Related]
2. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
8. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D
Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
12. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
13. Long term lorcainide therapy guided by electrophysiology studies.
Somberg J; Butler B; Flowers D; Tepper D; Torres V
Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
[TBL] [Abstract][Full Text] [Related]
14. Effect of procainamide on induced ventricular tachycardia.
Engel TR; del Gonzalez A; Meister SG; Franki WS
Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide.
Wynn J; Torres V; Flowers D; Mizruchi M; Keefe D; Miura D; Somberg J
Am Heart J; 1986 Apr; 111(4):632-8. PubMed ID: 3953384
[TBL] [Abstract][Full Text] [Related]
16. The antiarrhythmic effects of d-sotalol.
Schwartz J; Crocker K; Wynn J; Somberg JC
Am Heart J; 1987 Sep; 114(3):539-44. PubMed ID: 3630894
[TBL] [Abstract][Full Text] [Related]
17. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic effects of cibenzoline.
Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
[TBL] [Abstract][Full Text] [Related]
19. Long-term lorcainide therapy in patients with ventricular tachycardia.
Somberg J; Butler B; Flowers D; Keefe D; Torres V; Miura D
Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
[TBL] [Abstract][Full Text] [Related]
20. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
Nademanee K; Singh BN
Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
